Aşılama ve Aşıların Tarihçesi
Aşılar, sağlık alanındaki gelişmelerden daha fazla yaşam kurtarmıştır. Modern aşılar,1789’da Jenner’in çiçek aşısını geliştirmesi ile başlamıştır. O tarihten günümüze dek pekçok aşı geliştirilmiştir. Son iki yüzyılda aşılama alanında pek çok gelişme olmuştur. Pekçok ek aşı araştırma ve geliştirilme aşamasındadır. Günümüzde araştırmacılar mevcut aşılarıgeliştirmek ve HIV/AİDS gibi infeksiyonlar, kanserler ve bazı kronik hastalıklar ilesavaşmak için aşı geliştirmeye çalışmaktadırlar.
___
- 1. Plotkin S. History of vaccination. PNAS, 2014;111(34):12283–12287
2. Leungh AKC. “Variolation” and Vaccination in Late Imperial China,
Ca 1570–1911 in History of Vaccine Development ed. Plotkin SA.
Springer Science+Business Media, LLC 2011, London PP. 3-12.
3. Chris J. Hong An Historical Examination of Smallpox Vaccinations:
Past and Present Immunization Challenges
4. Riedel S. Edward Jenner and the history of smallpox and vaccination.
Bumc Proceedings 2005;18:21–25
5. Baxby D. Edward Jenner’s Role in the Introduction of Smallpox Vaccine
in History of Vaccine Development ed. Plotkin SA. Springer Science+
Business Media, LLC 2011, London PP. 13-20
6. İzgörer AG. Ahmed Cevdet Paşa tarafından yazılmış bazı tıbbi dokümanlar.
Yeni Tıp Tarihi araştırmaları. 1998: 4:23713.
7. Jenner F. Smallpox Eradication: The Vindication of Jenner’s Prophesy
in History of Vaccine Development ed. Plotkin SA. Springer Science+
Business Media, LLC 2011, London PP. 27-32
8. Stern AM, Markel H. The History Of Vaccines And Immunization: Familiar
Patterns, New Challenges. Health Affairs, 2005;24(3):611-621.
9. Bazin H. Pasteur and the Birth of Vaccines Made in the Laboratory.
in History of Vaccine Development ed. Plotkin SA. Springer
Science+Business Media, LLC 2011, London PP. 33-46.
10. Luca S, Mihaescu T, History of BCG Vaccine. MAEDICA, 2013; 8(1):
53-58.
11. Locht C. The Art & Science of Tuberculosis Vaccine Development
Chapter 5.1 The history of BCG
12. Gheorgiu M. Antituberculosis BCG Vaccine: Lessons from the
Past. in History of Vaccine Development ed. Plotkin SA. Springer Science+
Business Media, LLC 2011, London PP 47-55
13. McShane H. Tuberculosis vaccines: beyond bacille Calmette–Gueerin.
Phil. Trans. R. Soc. B (2011) 366, 2782–2789
14. Kaufmann SH, Gengenbacher M. Recombinant live vaccine candidates
against tuberculosis. Curr Opin Biotechnol. 2012;23(6):900-7.
15. Shapiro-Shapin CG. Pearl Kendrick, Grace Eldering, and the Pertussis
Vaccine. Emerging Infectious Diseases. 2010;16(8):1273-1279
16. Geier D, Geier M. The True Story of Pertussis Vaccination. A sordid
Legacy. Journal of History Medicine. 2002;57:249-285.
17. Granström M. The History of pertussis Vaccination: From Whole –Cell
to subunit Vaccines. in History of Vaccine Development ed. Plotkin SA.
Springer Science+Business Media, LLC 2011, London PP 73-82
18. Reliveld EH. History of Toksoid. in History of Vaccine Development
ed. Plotkin SA. Springer Science+Business Media, LLC 2011, London
PP 57-62
19. Baker RP, Katz SI. Childhood Vaccine Development: An Overview.
Pediatric Research 2004;55(2):347-359.
20. Katz SL, Wilfert CM, Robbins FC. The role of tissue culture in vaccine
development. in History of Vaccine Development ed. Plotkin SA.
Springer Science+Business Media, LLC 2011, London PP 145-149
21. Baicus A. History of polio vaccination. World J Virol. 2012;1(4):108-114
22. Baker JP. The first Measles Vaccine. Pediatrics 2011;128(5):435-437
23. Katz SL. The History of Measles Virus and the Development and Utilization
of Measles Virus Vaccines. in History of Vaccine Development
ed. Plotkin SA. Springer Science+Business Media, LLC 2011,
London PP 199-205.
24. Hilleman MR. The Development of Live Attenuated Mumps Virus Vaccine
in Historic Perspective and Its Role in the Evolution of Combined
Measles–Mumps–Rubella in in History of Vaccine Development
ed. Plotkin SA. Springer Science+Business Media, LLC 2011,
London
25. Plotkin SA. The History of Rubella and Rubella Vaccination Leading
to Elimination. Clinical Infectious Diseases 2006; 43:S164–168
26. Austrian R. Bacterial polysaccharide vaccines. in History of Vaccine
Development ed. Plotkin SA. Springer Science+Business Media,
LLC 2011, London PP 83-90
27. Robbins JB, Schneerson S, Szu SC, Pozsgay V. Polysaccharide –protein
conjugate vaccines. in History of Vaccine Development ed. Plotkin
SA. Springer Science+Business Media, LLC 2011, London PP
91-102.
28. Akdeniz M, mevsim G. Gripte güncel gelişmeler. Klinik Tıp Aile hekimliği,
2015;7(2): 7-15
29. Hilleman MR. Three decades of hepatitis vaccinology in historic perspective.
A paradigm of successful pursuit. in History of Vaccine Development
ed. Plotkin SA. Springer Science+Business Media, LLC
2011, London PP 233-246
30. Koff WC, Russel ND, Walport M, Feinberg MB et al. Accelerating
the development of a safe and effective HIV vaccine: HIV vaccine case
study for the Decade of Vaccines. Vaccine 31S (2013) B204– B208
31. Esperza J. A brief history of the global effort to develop a preventive
HIV vaccine. Vaccine 31 (2013) 3502– 3518
32. Kurugöl Z. Güncel aşılama. 57. Milli Pediatri Kongresi bildirileri.
30 Ekim - 03 Kasım 2013, Antalya
33. Topal M, Aşılar, Aşıların Üretimi Ve Ülkemizdeki Mevcut Durum. Erişim
www.keymen.com.tr. Erişim tarihi. 21.05.2015
34. Pharmaceutical Research and Manufacturers of America, Medicines
in Development Vaccines 2013. Erişim. http://www.phrma.org/media/
releases/nearly-300-vaccines-development-prevention-treatment-
disease. Erişim tarihi 21.05.2015
35. Nossal GJV. Vaccines and future global health. Phil. Trans. R. Soc.
B. 2011; 366, 2833–2840
36. Levine MM. “IDEAL” vaccines for resource poor settings. Vaccines
2011;29S:D116– D125
37. Wahren B, Liu MA. DNA Vaccines: Recent Developments and the Future.
Vaccines 2014, 2, 785-796
38. WHO (2013) Global Tuberculosis Control Report, 2013, Geneva:
World Health Organisation